| Lactose (India) Ltd | 123 Cr. | 97.8 | 197/84.3 | 27.2 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,486 Cr. | 320 | 479/192 | 72.2 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.3 Cr. | 43.6 | 82.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 66.4 Cr. | 45.4 | 45.6/17.0 | 158 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 69.0 Cr. | 91.6 | 115/69.7 | 18.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,124 Cr. | 1,989 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 297 Cr. | 12.2 | 17.2/10.8 | 17.8 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 821 Cr. | 1,530 | 1,999/635 | 28.4 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 90.2 Cr. | 18.0 | 29.8/17.0 | 24.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 942 Cr. | 320 | 449/219 | 8.41 | 133 | 0.78 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.07 Cr. | 14.6 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.14 Cr. | 3.27 | 8.28/2.11 | 4.62 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 415 Cr. | 427 | 536/211 | 62.6 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,961 Cr. | 1,140 | 1,565/944 | 44.9 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 43.0 Cr. | 0.21 | 1.12/0.20 | 2.82 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 31.6 Cr. | 12.0 | 26.3/11.2 | 15.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.70 Cr. | 7.62 | 15.2/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 155 Cr. | 434 | 851/415 | 8.78 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 72.0 Cr. | 72.0 | 92.5/26.1 | 136 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,535 Cr. | 1,198 | 2,452/1,176 | 39.0 | 174 | 0.87 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 8.39 Cr. | 66.6 | 88.7/36.1 | 17.1 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 19.6 Cr. | 131 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 65.2 Cr. | 119 | 144/9.41 | 45.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.6 Cr. | 40.5 | 73.0/33.0 | 49.3 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.27 Cr. | 20.9 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,311 Cr. | 421 | 1,028/416 | 20.8 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 75.1 Cr. | 17.4 | 29.6/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.2 Cr. | 22.0 | 37.5/17.4 | 48.5 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 86,604 Cr. | 2,098 | 2,727/2,059 | 52.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 223 Cr. | 388 | 524/241 | 22.9 | 123 | 1.16 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 55.6 Cr. | 38.7 | 47.9/26.7 | 86.8 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 65,779 Cr. | 1,133 | 1,279/994 | 19.2 | 603 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 138 Cr. | 222 | 303/159 | 132 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 725 Cr. | 72.3 | 115/68.0 | 18.7 | 32.6 | 2.08 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 32.8 Cr. | 25.1 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,319 Cr. | 1,749 | 1,902/930 | 64.0 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.06/0.51 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 183 Cr. | 23.9 | 53.8/23.1 | 11.7 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.20 Cr. | 12.3 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 130 Cr. | 5.52 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,947 Cr. | 27,740 | 37,000/25,260 | 39.1 | 1,888 | 1.72 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,920 Cr. | 763 | 972/557 | 28.9 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 195 Cr. | 68.8 | 100/31.3 | 54.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,405 Cr. | 1,304 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,972 Cr. | 1,352 | 1,870/1,110 | 400 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 577 Cr. | 165 | 330/154 | 13.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 66.7 Cr. | 8.05 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,040 Cr. | 778 | 849/272 | 16.4 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,629 Cr. | 373 | 760/361 | 18.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,369 Cr. | 969 | 1,402/951 | 19.6 | 768 | 1.03 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,32,975 Cr. | 3,929 | 4,125/2,886 | 61.4 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 735 Cr. | 79.8 | 255/76.0 | | 41.3 | 0.63 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,136 Cr. | 12.1 | 23.5/11.5 | 18.1 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,191 Cr. | 371 | 1,328/369 | 41.3 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 2,917 Cr. | 128 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,87,361 Cr. | 1,614 | 1,851/1,547 | 33.6 | 324 | 0.98 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,230 Cr. | 505 | 734/441 | 348 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,857 Cr. | 305 | 360/175 | 35.2 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,286 Cr. | 270 | 502/260 | 34.2 | 125 | 0.19 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,370 Cr. | 4,069 | 6,718/3,976 | 25.4 | 340 | 2.86 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,191 Cr. | 1,930 | 2,725/1,772 | 30.4 | 335 | 0.97 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,931 Cr. | 5,380 | 6,739/4,904 | 29.1 | 373 | 2.31 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 154 Cr. | 43.8 | 76.2/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,243 Cr. | 4,644 | 5,993/3,701 | 30.1 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 110 Cr. | 89.6 | 203/81.0 | 11.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,156 Cr. | 352 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,536 Cr. | 697 | 1,512/604 | 67.7 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,415 Cr. | 12,794 | 19,748/10,060 | 83.8 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 270 Cr. | 13.9 | 38.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,596 Cr. | 815 | 1,341/660 | 9.51 | 483 | 0.74 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,906 Cr. | 34.8 | 70.5/33.5 | 25.2 | 21.8 | 0.58 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,287 Cr. | 161 | 276/158 | 20.7 | 59.3 | 0.50 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 63.6 Cr. | 40.2 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 264 Cr. | 73.9 | 157/71.3 | 129 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 97,207 Cr. | 2,128 | 2,228/1,774 | 22.5 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 890 Cr. | 444 | 809/443 | 11.1 | 357 | 0.40 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,959 Cr. | 1,000 | 1,141/512 | 67.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,104 Cr. | 1,064 | 1,235/596 | 22.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 125 Cr. | 57.8 | 114/54.9 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 618 Cr. | 128 | 215/123 | 37.3 | 104 | 2.36 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 557 Cr. | 319 | 500/265 | 20.2 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 14,964 Cr. | 939 | 1,250/802 | 30.1 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,037 Cr. | 1,872 | 1,939/1,303 | 39.8 | 243 | 0.83 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,101 Cr. | 165 | 302/155 | 25.8 | 37.9 | 1.51 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,107 Cr. | 1,463 | 1,595/1,168 | 37.5 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,083 Cr. | 71.0 | 127/57.5 | 17.9 | 59.7 | 1.12 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 20.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 869 Cr. | 106 | 124/67.2 | 29.3 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,945 Cr. | 211 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,404 Cr. | 195 | 457/190 | 238 | 96.9 | 0.71 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,212 Cr. | 1,425 | 2,350/1,243 | 27.6 | 397 | 0.49 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,055 Cr. | 305 | 460/285 | 56.3 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,888 Cr. | 572 | 627/412 | 25.6 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,116 Cr. | 1,988 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 39,583 Cr. | 2,337 | 3,516/1,921 | 41.5 | 101 | 1.77 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,761 Cr. | 1,685 | 2,131/1,200 | 24.0 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,028 Cr. | 370 | 528/359 | 26.7 | 149 | 1.35 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,550 Cr. | 1,339 | 1,910/1,097 | 44.6 | 227 | 0.54 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,185 Cr. | 1,236 | 1,380/1,020 | 18.5 | 432 | 0.65 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,278 Cr. | 209 | 322/178 | 21.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,06,569 Cr. | 1,319 | 1,673/1,282 | 22.4 | 408 | 0.98 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,272 Cr. | 1,746 | 2,397/1,551 | 22.6 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 191 Cr. | 64.7 | 166/62.6 | 13.6 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,778 Cr. | 168 | 196/105 | 16.2 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 50.2 Cr. | 30.8 | 58.0/28.5 | 17.6 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,098 Cr. | 365 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,509 Cr. | 1,495 | 2,000/1,430 | 33.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 108 Cr. | 67.7 | 129/65.7 | 15.8 | 49.2 | 1.77 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 286 Cr. | 121 | 205/67.8 | 27.1 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 20,737 Cr. | 8,295 | 10,691/6,502 | 89.7 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,706 Cr. | 590 | 791/544 | 30.1 | 118 | 0.78 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 134 Cr. | 63.7 | 125/61.0 | 7.12 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,939 Cr. | 5,766 | 5,934/4,492 | 29.3 | 1,116 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,983 Cr. | 762 | 1,108/725 | 23.6 | 271 | 1.42 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 388 Cr. | 680 | 1,219/663 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,795 Cr. | 2,705 | 3,080/2,022 | 34.7 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,028 Cr. | 271 | 367/258 | 20.6 | 133 | 1.91 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,409 Cr. | 374 | 575/312 | 17.9 | 147 | 0.27 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,464.45 Cr | 1,082.43 | | 47.36 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |